Chemotherapy: cannabidiol to relieve pain
The pain-relieving properties of cannabis are already known and some countries such as the United Kingdom and Spain have already authorized its use for therapeutic purposes. It is consumed in the context of pathologies whose treatment is heavy such as chemotherapy. These can cause abnormal paincalled allodynias.
Researchers at temple university's school of pharmacy in Philadelphia demonstrated in a study published in Anesthesia - analgesia that one of the components of cannabis, cannabidiol (CBD), can relieve pain induced by paclitaxel, a drug used, among other things, for breast cancer.
Cannabidiol is known for its analgesic and anti-inflammatory properties. It has also been shown to reduce the activity of tumours in animals. But the main advantage of the molecule is that it does not cause a psychoactive effect like THC. For lead author Sara Jane Ward, "cannabidiol has the therapeutic qualities of cannabis without the side effects. The study of 146 mice (26 males and 120 females) under going on paclitaxel treatment shows that CBD completely prevents the chills and pain induced by the chemotherapy drug. In addition, stopping CBD did not result in neuropathic disorders.
Cannabidiol is of great interest to researchers, as evidenced by the number of clinical studies currently being conducted in the United States. Many avenues are being explored to test its effectiveness for certain inflammatory diseases, psychiatric including the phenomenon of addiction.
On Tuesday, October 4, 2011, a patient with multiple sclerosis was convicted but spared punishment for growing cannabis in order to relieve his pain. Its therapeutic use remains prohibited in France.
Researchers at temple university's school of pharmacy in Philadelphia demonstrated in a study published in Anesthesia - analgesia that one of the components of cannabis, cannabidiol (CBD), can relieve pain induced by paclitaxel, a drug used, among other things, for breast cancer.
Cannabidiol is known for its analgesic and anti-inflammatory properties. It has also been shown to reduce the activity of tumours in animals. But the main advantage of the molecule is that it does not cause a psychoactive effect like THC. For lead author Sara Jane Ward, "cannabidiol has the therapeutic qualities of cannabis without the side effects. The study of 146 mice (26 males and 120 females) under going on paclitaxel treatment shows that CBD completely prevents the chills and pain induced by the chemotherapy drug. In addition, stopping CBD did not result in neuropathic disorders.
Cannabidiol is of great interest to researchers, as evidenced by the number of clinical studies currently being conducted in the United States. Many avenues are being explored to test its effectiveness for certain inflammatory diseases, psychiatric including the phenomenon of addiction.
On Tuesday, October 4, 2011, a patient with multiple sclerosis was convicted but spared punishment for growing cannabis in order to relieve his pain. Its therapeutic use remains prohibited in France.